GLP-1 Market: Transforming Diabetes and Obesity Treatment
The GLP-1 Market is being shaped by clinical innovation, demographic change, and evolving supply and regulatory conditions. Valued at USD 52.82 billion in 2025, the GLP-1 Market is projected to reach USD 58.48 billion in 2026 and USD 133.92 billion by 2034, growing at a CAGR of 10.9% during the forecast period 2026–2034. Key players include AstraZeneca, Boehringer Ingelheim, D&D...
